Views: 0 Author: Site Editor Publish Time: 2025-07-10 Origin: Site
CAS No. 5911-08-0, also known as 2,6-Dichlorobenzyl chloride, is a halogenated aromatic compound widely used in the synthesis of various antiviral, antiseptic, and antiretroviral pharmaceutical products. As a key structural fragment, it is frequently found in active pharmaceutical ingredients (APIs) for throat lozenges, cold medications, and anti-HIV therapies.
Due to its electrophilic nature and reactivity toward nucleophilic substitution, this compound serves as a reliable building block in pharmaceutical chemistry.
Commonly incorporated in drugs aimed at treating sore throat, cold symptoms, and respiratory infections.
Plays a crucial role in the synthesis of several benzyl-based intermediates and final APIs.
Its dual halogen groups allow versatile substitution and controlled downstream synthesis.
Used in over-the-counter (OTC) and prescription antivirals and antiseptics.
Manufacturing must meet stringent standards related to chlorinated aromatic compounds.
Location: Indianapolis, Indiana, USA
Overview: A recognized producer of halogenated aromatics and benzyl derivatives.
Specialty: High-purity intermediates for antiviral and antiseptic formulations.
Location: Uttar Pradesh, India
Overview: A major global supplier of chlorinated benzenes and their derivatives for pharma use.
Specialty: Backward-integrated, with consistent batch quality for regulated markets.
Location: Changzhou City, Jiangsu Province, China
Overview: A key supplier of 2,6-Dichlorobenzyl chloride for antiviral and throat-relief APIs.
Specialty: Competitive pricing, fast delivery, and export-ready documentation.
Location: Maharashtra, India
Overview: Specializes in halogenated intermediates used in anti-infective and respiratory drugs.
Specialty: Robust environmental controls and compliance with USFDA and EDQM norms.
Location: Frankfurt, Germany
Overview: Experienced in aromatic substitution chemistry and complex chlorinated intermediates.
Specialty: Custom manufacturing under strict European quality systems.
Location: Hyderabad, India
Overview: Supplies intermediates for APIs targeting infectious diseases and respiratory illnesses.
Specialty: Full analytical and regulatory support for global filings.
Location: Barcelona, Spain
Overview: European CDMO with broad capabilities in benzyl and halogenated compound synthesis.
Specialty: Strong regulatory track record and flexible scale production.
Location: Montreal, Canada
Overview: North American supplier of benzyl derivatives used in antiviral drug manufacturing.
Specialty: Focus on impurity control and cGMP-compliant delivery.
Location: Massachusetts, USA
Overview: Specializes in halogenated and labeled intermediates for research and clinical applications.
Specialty: High-purity, small-scale batches for preclinical and formulation R&D.
Location: Newcastle, UK
Overview: Offers halogenated intermediate production as part of its global CDMO services.
Specialty: Strong quality assurance and containment for regulated markets.
CAS 5911-08-0 has seen rising demand due to increased awareness of upper respiratory infections.
Intermediate is critical for producing common antiseptics and cold remedies used worldwide.
Manufacturers are upgrading facilities to handle chlorinated compounds safely and efficiently.
Intermediates containing halogens face stricter global quality, storage, and environmental controls.
Buyers are prioritizing international suppliers with strong compliance and secure logistics.
CAS No. 5911-08-0—2,6-Dichlorobenzyl chloride—is an essential intermediate in the manufacture of antiviral and antiseptic pharmaceutical products. Leading global manufacturers such as Eastfine, Vertellus, Jubilant, and WeylChem are supporting global healthcare needs by producing this compound at scale and with high-quality standards.
With increasing demand for OTC respiratory products and stricter regulatory requirements, trusted suppliers of CAS 5911-08-0 will continue to play a crucial role in pharmaceutical supply chains around the world.
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 2550-36-9 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 872-53-7 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 3721-95-7 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 88-09-5 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 5911-08-0 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 317-46-4 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 17247-58-4 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 951-82-6 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 32122-23-9 in 2025
Top 10 Manufacturers of Pharmaceutical Intermediate CAS No. 1802242-47-2 in 2025